The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
Annual Meeting Lung Cancer Press Conference - May 30, 2009 11:00 AM
Studies Advance Treatment and Understanding of Lung Cancer
Orlando, Fla. - The findings from several large studies on lung cancer were released today at a press briefing at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).
“Lung cancer is one of the most challenging cancers to treat, but the studies presented today highlight promising new targeted therapies and milder treatment regimens that improve survival,” said Bruce E. Johnson, MD, Director of the Dana-Farber Harvard Medical Center Lung Cancer Program and moderator of the press briefing. “Researchers also report that hormone therapy among menopausal women with lung cancer is associated with a higher risk of death. These findings add to growing concerns about the safety of hormone therapy.”
